Pseudorabies Virus dUTPase UL50 Induces Lysosomal Degradation of Type I Interferon Receptor 1 and Antagonizes the Alpha Interferon Response

J Virol. 2017 Oct 13;91(21):e01148-17. doi: 10.1128/JVI.01148-17. Print 2017 Nov 1.

Abstract

Alphaherpesviruses that establish persistent infections rely partly on their ability to evade host antiviral responses, notably the type I interferon (IFN) response. However, the mechanisms employed by alphaherpesviruses to avoid this response are not well understood. Pseudorabies virus (PRV) is an economically important pathogen and a useful model system for studying alphaherpesvirus biology. To identify PRV proteins that antagonize type I IFN signaling, we performed a screen by using an IFN-stimulated response element reporter in the swine cell line CRL. Unexpectedly, we identified the dUTPase UL50 as a strong inhibitor. We confirmed that UL50 has the ability to inhibit type I IFN signaling by performing ectopic expression of UL50 in cells and deletion of UL50 in PRV. Mechanistically, UL50 impeded type I IFN-induced STAT1 phosphorylation, likely by accelerating lysosomal degradation of IFN receptor 1 (IFNAR1). In addition, this UL50 activity was independent of its dUTPase activity and required amino acids 225 to 253 in the C-terminal region. The UL50 encoded by herpes simplex virus 1 (HSV-1) also possessed similar activity. Moreover, UL50-deleted PRV was more susceptible to IFN than UL50-proficient PRV. Our results suggest that in addition to its dUTPase activity, the UL50 protein of alphaherpesviruses possesses the ability to suppress type I IFN signaling by promoting lysosomal degradation of IFNAR1, thereby contributing to immune evasion. This finding reveals UL50 as a potential antiviral target.IMPORTANCE Alphaherpesviruses can establish lifelong infections and cause many diseases in humans and animals. Pseudorabies virus (PRV) is a swine alphaherpesvirus that threatens pig production. Using PRV as a model, we found that this alphaherpesvirus could utilize its encoded dUTPase UL50 to induce IFNAR1 degradation and inhibit type I IFN signaling in an enzymatic activity-independent manner. Our finding reveals a mechanism employed by an alphaherpesvirus to evade the immune response and indicates that UL50 is an important viral protein in pathogenesis and is a potential target for antiviral drug development.

Keywords: alphaherpesviruses; dUTPase UL50; interferon signaling; pseudorabies virus; type I interferon receptor 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antiviral Agents / pharmacology
  • HeLa Cells
  • Herpesvirus 1, Suid / enzymology*
  • Herpesvirus 1, Suid / genetics
  • Humans
  • Immune Evasion
  • Interferon Type I / pharmacology*
  • Kidney / drug effects
  • Kidney / metabolism
  • Kidney / virology
  • Lysosomes / metabolism*
  • Phosphorylation
  • Proteolysis
  • Pseudorabies / drug therapy
  • Pseudorabies / metabolism*
  • Pseudorabies / virology
  • Pyrophosphatases / genetics
  • Pyrophosphatases / metabolism*
  • Receptor, Interferon alpha-beta / genetics
  • Receptor, Interferon alpha-beta / metabolism*
  • Sequence Homology
  • Signal Transduction
  • Swine
  • Viral Proteins / genetics
  • Viral Proteins / metabolism

Substances

  • Antiviral Agents
  • IFNAR1 protein, human
  • Interferon Type I
  • Viral Proteins
  • Receptor, Interferon alpha-beta
  • Pyrophosphatases
  • dUTP pyrophosphatase